Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
PGRP-S CRISPR/Cas9 KO Plasmid (m): sc-423451
- Target species: mouse
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- PGRP-S CRISPR/Cas9 Knockout (KO) Plasmid (m) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the PGRP-S genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: PGRP-S Antibody (G-1): sc-365304
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PGRP-S CRISPR/Cas9 KO Plasmid (m) | sc-423451 | 20 µg | $397.00 |
Overview
Pglyrp1 encodes peptidoglycan recognition protein S (PGRP-S), a secreted pattern-recognition molecule that binds bacterial peptidoglycan and contributes to innate immune surveillance. In mice, PGRP-S helps modulate antimicrobial responses and inflammatory signaling at mucosal and systemic sites by shaping leukocyte activation and microbial sensing pathways. Altered PGRP family activity has been linked to dysregulated host–microbe interactions, susceptibility to infection, and inflammatory phenotypes relevant to barrier tissues. Pglyrp1 is therefore studied in the context of innate immune homeostasis, microbiome-dependent immunity, and inflammation-associated disease models.
PGRP-S CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Pglyrp1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Pglyrp1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Pglyrp1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PGRP-S protein expression.
This CRISPR knockout system enables efficient generation of Pglyrp1-deficient cell models for investigation of PGRP-S signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting Pglyrp1 exon(s) critical for PGRP-S function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple Pglyrp1 genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by PGRP-S CRISPR/Cas9 KO Plasmid (m) and PGRP-S CRISPR/Cas9 KO Plasmid (m2) target distinct sites within the Pglyrp1 locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by PGRP-S HDR Plasmid (m) and PGRP-S HDR Plasmid (m2) contain a puromycin resistance cassette and an RFP reporter flanked by Pglyrp1 homology arms to support homology-directed repair at defined Pglyrp1 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.